Even in a fully integrated healthcare system, only 28% of cancer quality measures could be validated by using electronically available data.
Jeremy B. Shelton, MD, MSHS
Advertisement
Articles by Jeremy B. Shelton, MD, MSHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
Counseling Vitiligo Patients on Time to Repigmentation
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5